David C. Danko
Research Subjects
David C. Danko has a total of 286 co-authors. Here are the top co-authors by number of shared publications:
- Christopher E. Mason
Department of Physiology and Biophysics, Weill Cornell Medicine, New York, USA
11 shared publications - Iman Hajirasouliha
Department of Systems and Computational Biomedicine, Weill Cornell Medicine of Cornell University, New York, USA
5 shared publications - Maria A. Sierra
Tri-Institutional Computational Biology, Weill Cornell Medicine, New York, USA
4 shared publications Christopher E. Mason
Biotia Inc., New York, NY, USA
3 shared publications- Daniela Bezdan
Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany
3 shared publications Dmitry Meleshko
Weill Cornell Medicine 1300 York Ave
3 shared publications
Latest Publications
- Open Access
BIOTIA-DX RESISTANCE Achieved the Best Antimicrobial Resistance Phenotype Prediction Accuracy at CAMDA 2026
We present BIOTIA-DX RESISTANCE (BDXR), our submission to the CAMDA 2026 AMR Challenge. This work extends our CAMDA 2025 submission [1] to a new set of six species-drug pairs and adds k-mer-based feature engineering (both targeted and whole-genome) for pairs where the 2025 gene-presence base model underperforms. BDXR achieved a mean accuracy of 86.1% across the six pairs on the CAMDA 2026 test set, ranking first on four pairs, tied for first on Streptococcus pneumoniae (penicillin), and second on Campylobacter jejuni (nalidixic acid); per-pair test accuracy ranged from 69.9% ( C. jejuni , nalidixic acid) to 98.8% ( S. pneumoniae , penicillin). We refer the reader to our 2025 preprint [1] for the underlying workflow, dataset curation, and clinical motivation; this preprint focuses on the results and methodological changes that are new in 2026.
Open AccessBIOTIA-DX RESISTANCE Achieved the Best Antimicrobial Resistance Phenotype Prediction Accuracy at CAMDA 2026
We present BIOTIA-DX RESISTANCE (BDXR), our submission to the CAMDA 2026 AMR Challenge. This work extends our CAMDA 2025 submission [1] to a new set of six species-drug pairs and adds k-mer-based feature engineering (both targeted and whole-genome) for pairs where the 2025 gene-presence base model underperforms. BDXR achieved a mean accuracy of 86.1% across the six pairs on the CAMDA 2026 test set, ranking first on four pairs, tied for first on Streptococcus pneumoniae (penicillin), and second on Campylobacter jejuni (nalidixic acid); per-pair test accuracy ranged from 69.9% ( C. jejuni , nalidixic acid) to 98.8% ( S. pneumoniae , penicillin). We refer the reader to our 2025 preprint [1] for the underlying workflow, dataset curation, and clinical motivation; this preprint focuses on the results and methodological changes that are new in 2026.
- Open Access
XTree enables memory-efficient, accurate short and long sequence alignment to millions of genomes across the tree of life
XTree is a k-mer-based aligner enabling rapid, memory-efficient alignment of sequencing reads to whole-genome reference databases with up to millions of genomes. Here, we detail XTree’s performance on short and long read sequencing data and demonstrate its high accuracy across diverse bacterial, viral, and eukaryotic genomes. Benchmarking demonstrates superior and/or comparable precision and recall over existing tools, with more scalable indexing and efficient memory mapping. We additionally provide pre-indexed databases, including (1) the Genome Taxonomy Database (versions r214-r226), (2) representative GenBank fungi and protozoan genomes and (3) the Pan-Viral-Compendium, a bespoke data resource spanning 6.6 million, quality-controlled, viral genomes.
Open AccessXTree enables memory-efficient, accurate short and long sequence alignment to millions of genomes across the tree of life
XTree is a k-mer-based aligner enabling rapid, memory-efficient alignment of sequencing reads to whole-genome reference databases with up to millions of genomes. Here, we detail XTree’s performance on short and long read sequencing data and demonstrate its high accuracy across diverse bacterial, viral, and eukaryotic genomes. Benchmarking demonstrates superior and/or comparable precision and recall over existing tools, with more scalable indexing and efficient memory mapping. We additionally provide pre-indexed databases, including (1) the Genome Taxonomy Database (versions r214-r226), (2) representative GenBank fungi and protozoan genomes and (3) the Pan-Viral-Compendium, a bespoke data resource spanning 6.6 million, quality-controlled, viral genomes.
- Open Access
BIOTIA-DX RESISTANCE Achieved the Best Antimicrobial Resistance Phenotype Prediction Accuracy at CAMDA 2025
We have developed BIOTIA-DX RESISTANCE (BDXR), a bioinformatic tool for predicting antimicrobial resistance (AMR) from whole genome sequencing of microbial isolates. BDXR achieved the best accuracy of any submission to the CAMDA 2025 AMR Challenge. This year’s challenge focused on predicting AMR phenotype which is a more complex problem than the detection of AMR marker genes, the focus of some prior years. BDXR achieved an overall F1 score of 89% on the training set and 84.1% on the challenge test set. Accuracy varied across the 9 species and drug pairs in the competition from an F1 score of 98.4% ( Campylobacter jejuni , tetracycline) to 78.5% ( Pseudomonas aeruginosa , cefatzidime). BDXR is based on curation of global datasets, machine learning-based predictions from input data, and highly stringent prepreprocessing of input data and databases.
Open AccessBIOTIA-DX RESISTANCE Achieved the Best Antimicrobial Resistance Phenotype Prediction Accuracy at CAMDA 2025
We have developed BIOTIA-DX RESISTANCE (BDXR), a bioinformatic tool for predicting antimicrobial resistance (AMR) from whole genome sequencing of microbial isolates. BDXR achieved the best accuracy of any submission to the CAMDA 2025 AMR Challenge. This year’s challenge focused on predicting AMR phenotype which is a more complex problem than the detection of AMR marker genes, the focus of some prior years. BDXR achieved an overall F1 score of 89% on the training set and 84.1% on the challenge test set. Accuracy varied across the 9 species and drug pairs in the competition from an F1 score of 98.4% ( Campylobacter jejuni , tetracycline) to 78.5% ( Pseudomonas aeruginosa , cefatzidime). BDXR is based on curation of global datasets, machine learning-based predictions from input data, and highly stringent prepreprocessing of input data and databases.
- Open Access
Blackbird: structural variant detection using synthetic and low-coverage long-reads
Recent benchmarks of structural variant (SV) detection tools revealed that the majority of human genome structural variations (SVs), especially the medium-range (50-10,000 bp) SVs cannot be resolved with short-read sequencing, but long-read SV callers achieve great results on the same datasets. While improvements have been made, high-coverage long-read sequencing is associated with higher costs and input DNA requirements. To decrease the cost one can lower the sequence coverage, but the current long-read SV callers perform poorly with coverage below 10X. Synthetic long-read (SLR) technologies hold great potential for structural variant (SV) detection, although utilizing their long-range information for events smaller than 50 kbp has been challenging. Results: In this work, we propose a hybrid novel integrated alignment- and local-assembly-based algorithm, Blackbird, that uses SLR together with low-coverage long reads to improve SV detection and assembly. Without the need for a computationally expensive whole genome assembly, Blackbird uses a sliding window approach and barcode information encoded in SLR to accurately assemble small segments and use long reads for an improved gap closing and contig assembly. We evaluated Blackbird on simulated and real human genome datasets. Using the HG002 GIAB benchmark set, we demonstrated that in hybrid mode, Blackbird demonstrated results comparable to state-of-the-art long-read tools, while using less long-read coverage. Blackbird requires only 5X coverage to achieve F1 scores (0.835 and 0.808 for deletions and insertions) similar to PBSV (0.856 and 0.812) and Sniffles2 (0.839 and 0.804) using 10X Pacbio Hi-Fi long-read coverage.
Open AccessBlackbird: structural variant detection using synthetic and low-coverage long-reads
Recent benchmarks of structural variant (SV) detection tools revealed that the majority of human genome structural variations (SVs), especially the medium-range (50-10,000 bp) SVs cannot be resolved with short-read sequencing, but long-read SV callers achieve great results on the same datasets. While improvements have been made, high-coverage long-read sequencing is associated with higher costs and input DNA requirements. To decrease the cost one can lower the sequence coverage, but the current long-read SV callers perform poorly with coverage below 10X. Synthetic long-read (SLR) technologies hold great potential for structural variant (SV) detection, although utilizing their long-range information for events smaller than 50 kbp has been challenging. Results: In this work, we propose a hybrid novel integrated alignment- and local-assembly-based algorithm, Blackbird, that uses SLR together with low-coverage long reads to improve SV detection and assembly. Without the need for a computationally expensive whole genome assembly, Blackbird uses a sliding window approach and barcode information encoded in SLR to accurately assemble small segments and use long reads for an improved gap closing and contig assembly. We evaluated Blackbird on simulated and real human genome datasets. Using the HG002 GIAB benchmark set, we demonstrated that in hybrid mode, Blackbird demonstrated results comparable to state-of-the-art long-read tools, while using less long-read coverage. Blackbird requires only 5X coverage to achieve F1 scores (0.835 and 0.808 for deletions and insertions) similar to PBSV (0.856 and 0.812) and Sniffles2 (0.839 and 0.804) using 10X Pacbio Hi-Fi long-read coverage.
- Open Access
Forecasting Dengue Fever in Brazil Using Multimodal Data, Including Climate Data
Dengue fever is a major tropical disease transmitted by Aedes mosquitoes. Dengue affects more than 120 countries with highly variable year to year infection rates. Despite high variability, dengue has a clear relationship to climate factors and human demography. Global trends to higher temperatures and greater disorderly urban development are increasing the scale and scope of dengue risk. Dengue has complex human immunity with 4 known serotypes that make multiple infections possible. Accurate forecasting of dengue fever would allow for appropriate interventions and improved public health outcomes. We demonstrate, GeoSeeq Dengue , a forecasting model for dengue fever in Brazil. GeoSeeq Dengue predicts dengue outbreaks monthly in 5,570 Brazilian municipalities at 1, 3, and 6 months ahead of the outbreak. Model accuracy compares favorably to a historical baseline model, making it a promising model for informing public health response. We evaluate how different types of input variables effect model accuracy and explore how this model could be adapted to other countries. This model could inform public health responses to dengue including targeting vector control programs, public health education messaging, and the newly launched dengue vaccine rollout.
Open AccessForecasting Dengue Fever in Brazil Using Multimodal Data, Including Climate Data
Dengue fever is a major tropical disease transmitted by Aedes mosquitoes. Dengue affects more than 120 countries with highly variable year to year infection rates. Despite high variability, dengue has a clear relationship to climate factors and human demography. Global trends to higher temperatures and greater disorderly urban development are increasing the scale and scope of dengue risk. Dengue has complex human immunity with 4 known serotypes that make multiple infections possible. Accurate forecasting of dengue fever would allow for appropriate interventions and improved public health outcomes. We demonstrate, GeoSeeq Dengue , a forecasting model for dengue fever in Brazil. GeoSeeq Dengue predicts dengue outbreaks monthly in 5,570 Brazilian municipalities at 1, 3, and 6 months ahead of the outbreak. Model accuracy compares favorably to a historical baseline model, making it a promising model for informing public health response. We evaluate how different types of input variables effect model accuracy and explore how this model could be adapted to other countries. This model could inform public health responses to dengue including targeting vector control programs, public health education messaging, and the newly launched dengue vaccine rollout.
- Open Access
- 1 May 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (9)
Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege
Multiple sclerosis (MS) is a complex disease of the CNS thought to require an environmental trigger. Gut dysbiosis is common in MS, but specific causative species are unknown. To address this knowledge gap, we used sensitive and quantitative PCR detection to show that people with MS were more likely to harbor and show a greater abundance of epsilon toxin–producing (ETX-producing) strains of C. perfringens within their gut microbiomes compared with individuals who are healthy controls (HCs). Isolates derived from patients with MS produced functional ETX and had a genetic architecture typical of highly conjugative plasmids. In the active immunization model of experimental autoimmune encephalomyelitis (EAE), where pertussis toxin (PTX) is used to overcome CNS immune privilege, ETX can substitute for PTX. In contrast to PTX-induced EAE, where inflammatory demyelination is largely restricted to the spinal cord, ETX-induced EAE caused demyelination in the corpus callosum, thalamus, cerebellum, brainstem, and spinal cord, more akin to the neuroanatomical lesion distribution seen in MS. CNS endothelial cell transcriptional profiles revealed ETX-induced genes that are known to play a role in overcoming CNS immune privilege. Together, these findings suggest that ETX-producing C. perfringens strains are biologically plausible pathogens in MS that trigger inflammatory demyelination in the context of circulating myelin autoreactive lymphocytes.
- 1 May 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (9)
Open AccessEpsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege
Multiple sclerosis (MS) is a complex disease of the CNS thought to require an environmental trigger. Gut dysbiosis is common in MS, but specific causative species are unknown. To address this knowledge gap, we used sensitive and quantitative PCR detection to show that people with MS were more likely to harbor and show a greater abundance of epsilon toxin–producing (ETX-producing) strains of C. perfringens within their gut microbiomes compared with individuals who are healthy controls (HCs). Isolates derived from patients with MS produced functional ETX and had a genetic architecture typical of highly conjugative plasmids. In the active immunization model of experimental autoimmune encephalomyelitis (EAE), where pertussis toxin (PTX) is used to overcome CNS immune privilege, ETX can substitute for PTX. In contrast to PTX-induced EAE, where inflammatory demyelination is largely restricted to the spinal cord, ETX-induced EAE caused demyelination in the corpus callosum, thalamus, cerebellum, brainstem, and spinal cord, more akin to the neuroanatomical lesion distribution seen in MS. CNS endothelial cell transcriptional profiles revealed ETX-induced genes that are known to play a role in overcoming CNS immune privilege. Together, these findings suggest that ETX-producing C. perfringens strains are biologically plausible pathogens in MS that trigger inflammatory demyelination in the context of circulating myelin autoreactive lymphocytes.
- Open Access
Ozone Disinfection for Elimination of Bacteria and Degradation of SARS-CoV2 RNA for Medical Environments
Pathogenic bacteria and viruses in medical environments can lead to treatment complications and hospital-acquired infections. Current disinfection protocols do not address hard-to-access areas or may be beyond line-of-sight treatment, such as with ultraviolet radiation. The COVID-19 pandemic further underscores the demand for reliable and effective disinfection methods to sterilize a wide array of surfaces and to keep up with the supply of personal protective equipment (PPE). We tested the efficacy of Sani Sport ozone devices to treat hospital equipment and surfaces for killing Escherichia coli, Enterococcus faecalis, Bacillus subtilis, and Deinococcus radiodurans by assessing Colony Forming Units (CFUs) after 30 min, 1 h, and 2 h of ozone treatment. Further gene expression analysis was conducted on live E. coli K12 immediately post treatment to understand the oxidative damage stress response transcriptome profile. Ozone treatment was also used to degrade synthetic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA as assessed by qPCR CT values. We observed significant and rapid killing of medically relevant and environmental bacteria across four surfaces (blankets, catheter, remotes, and syringes) within 30 min, and up to a 99% reduction in viable bacteria at the end of 2 h treatment cycles. RNA-seq analysis of E. coli K12 revealed 447 differentially expressed genes in response to ozone treatment and an enrichment for oxidative stress response and related pathways. RNA degradation of synthetic SARS-CoV-2 RNA was seen an hour into ozone treatment as compared to non-treated controls, and a non-replicative form of the virus was shown to have significant RNA degradation at 30 min. These results show the strong promise of ozone treatment of surfaces for reducing the risk of hospital-acquired infections and as a method for degradation of SARS-CoV-2 RNA.
Open AccessOzone Disinfection for Elimination of Bacteria and Degradation of SARS-CoV2 RNA for Medical Environments
Pathogenic bacteria and viruses in medical environments can lead to treatment complications and hospital-acquired infections. Current disinfection protocols do not address hard-to-access areas or may be beyond line-of-sight treatment, such as with ultraviolet radiation. The COVID-19 pandemic further underscores the demand for reliable and effective disinfection methods to sterilize a wide array of surfaces and to keep up with the supply of personal protective equipment (PPE). We tested the efficacy of Sani Sport ozone devices to treat hospital equipment and surfaces for killing Escherichia coli, Enterococcus faecalis, Bacillus subtilis, and Deinococcus radiodurans by assessing Colony Forming Units (CFUs) after 30 min, 1 h, and 2 h of ozone treatment. Further gene expression analysis was conducted on live E. coli K12 immediately post treatment to understand the oxidative damage stress response transcriptome profile. Ozone treatment was also used to degrade synthetic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA as assessed by qPCR CT values. We observed significant and rapid killing of medically relevant and environmental bacteria across four surfaces (blankets, catheter, remotes, and syringes) within 30 min, and up to a 99% reduction in viable bacteria at the end of 2 h treatment cycles. RNA-seq analysis of E. coli K12 revealed 447 differentially expressed genes in response to ozone treatment and an enrichment for oxidative stress response and related pathways. RNA degradation of synthetic SARS-CoV-2 RNA was seen an hour into ozone treatment as compared to non-treated controls, and a non-replicative form of the virus was shown to have significant RNA degradation at 30 min. These results show the strong promise of ozone treatment of surfaces for reducing the risk of hospital-acquired infections and as a method for degradation of SARS-CoV-2 RNA.
- 22 July 2021
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 103 (18) , 1705-1712
Sequencing of Circulating Microbial Cell-Free DNA Can Identify Pathogens in Periprosthetic Joint Infections
Background: Over 1 million Americans undergo joint replacement each year, and approximately 1 in 75 will incur a periprosthetic joint infection. Effective treatment necessitates pathogen identification, yet standard-of-care cultures fail to detect organisms in 10% to 20% of cases and require invasive sampling. We hypothesized that cell-free DNA (cfDNA) fragments from microorganisms in a periprosthetic joint infection can be found in the bloodstream and utilized to accurately identify pathogens via next-generation sequencing. Methods: In this prospective observational study performed at a musculoskeletal specialty hospital in the U.S., we enrolled 53 adults with validated hip or knee periprosthetic joint infections. Participants had peripheral blood drawn immediately prior to surgical treatment. Microbial cfDNA from plasma was sequenced and aligned to a genome database with >1,000 microbial species. Intraoperative tissue and synovial fluid cultures were performed per the standard of care. The primary outcome was accuracy in organism identification with use of blood cfDNA sequencing, as measured by agreement with tissue-culture results. Results: Intraoperative and preoperative joint cultures identified an organism in 46 (87%) of 53 patients. Microbial cfDNA sequencing identified the joint pathogen in 35 cases, including 4 of 7 culture-negative cases (57%). Thus, as an adjunct to cultures, cfDNA sequencing increased pathogen detection from 87% to 94%. The median time to species identification for cases with genus-only culture results was 3 days less than standard-of-care methods. Circulating cfDNA sequencing in 14 cases detected additional microorganisms not grown in cultures. At postoperative encounters, cfDNA sequencing demonstrated no detection or reduced levels of the infectious pathogen. Conclusions: Microbial cfDNA from pathogens causing local periprosthetic joint infections can be detected in peripheral blood. These circulating biomarkers can be sequenced from noninvasive venipuncture, providing a novel source for joint pathogen identification. Further development as an adjunct to tissue cultures holds promise to increase the number of cases with accurate pathogen identification and improve time-to-speciation. This test may also offer a novel method to monitor infection clearance during the treatment period. Level of Evidence: Diagnostic Level II. See Instructions for Authors for a complete description of levels of evidence.
- 22 July 2021
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 103 (18) , 1705-1712
Sequencing of Circulating Microbial Cell-Free DNA Can Identify Pathogens in Periprosthetic Joint Infections
Background: Over 1 million Americans undergo joint replacement each year, and approximately 1 in 75 will incur a periprosthetic joint infection. Effective treatment necessitates pathogen identification, yet standard-of-care cultures fail to detect organisms in 10% to 20% of cases and require invasive sampling. We hypothesized that cell-free DNA (cfDNA) fragments from microorganisms in a periprosthetic joint infection can be found in the bloodstream and utilized to accurately identify pathogens via next-generation sequencing. Methods: In this prospective observational study performed at a musculoskeletal specialty hospital in the U.S., we enrolled 53 adults with validated hip or knee periprosthetic joint infections. Participants had peripheral blood drawn immediately prior to surgical treatment. Microbial cfDNA from plasma was sequenced and aligned to a genome database with >1,000 microbial species. Intraoperative tissue and synovial fluid cultures were performed per the standard of care. The primary outcome was accuracy in organism identification with use of blood cfDNA sequencing, as measured by agreement with tissue-culture results. Results: Intraoperative and preoperative joint cultures identified an organism in 46 (87%) of 53 patients. Microbial cfDNA sequencing identified the joint pathogen in 35 cases, including 4 of 7 culture-negative cases (57%). Thus, as an adjunct to cultures, cfDNA sequencing increased pathogen detection from 87% to 94%. The median time to species identification for cases with genus-only culture results was 3 days less than standard-of-care methods. Circulating cfDNA sequencing in 14 cases detected additional microorganisms not grown in cultures. At postoperative encounters, cfDNA sequencing demonstrated no detection or reduced levels of the infectious pathogen. Conclusions: Microbial cfDNA from pathogens causing local periprosthetic joint infections can be detected in peripheral blood. These circulating biomarkers can be sequenced from noninvasive venipuncture, providing a novel source for joint pathogen identification. Further development as an adjunct to tissue cultures holds promise to increase the number of cases with accurate pathogen identification and improve time-to-speciation. This test may also offer a novel method to monitor infection clearance during the treatment period. Level of Evidence: Diagnostic Level II. See Instructions for Authors for a complete description of levels of evidence.
- Open Access
Genetic and Immunological Evidence for Microbial Transfer Between the International Space Station and an Astronaut
Microbial transfer from the environment can influence a person’s health, but relevant studies often have confounding variables and short durations. Here, we used the unique environment of the International Space Station (ISS) to track movement of microbes between an astronaut’s commensal microbiomes and their environment. We identified several microbial taxa, including Serratia proteamaculans and Rickettsia australis which appear to have been transferred from the ISS to the commensal microbiomes of the astronaut. Strains were matched at the SNP and haplotype-level, and notably some strains persisted even after the astronaut’s return to Earth. Some transferred taxa correspond to secondary strains in the ISS environment, suggesting that transfer may be mediated by evolutionary selection. Finally, we show evidence that the T-Cell repertoire of the astronaut changes to become more specific to environmental taxa, suggesting that continual microbial and immune monitoring can help guide spaceflight mission planning, health monitoring, and habitat design.
Open AccessGenetic and Immunological Evidence for Microbial Transfer Between the International Space Station and an Astronaut
Microbial transfer from the environment can influence a person’s health, but relevant studies often have confounding variables and short durations. Here, we used the unique environment of the International Space Station (ISS) to track movement of microbes between an astronaut’s commensal microbiomes and their environment. We identified several microbial taxa, including Serratia proteamaculans and Rickettsia australis which appear to have been transferred from the ISS to the commensal microbiomes of the astronaut. Strains were matched at the SNP and haplotype-level, and notably some strains persisted even after the astronaut’s return to Earth. Some transferred taxa correspond to secondary strains in the ISS environment, suggesting that transfer may be mediated by evolutionary selection. Finally, we show evidence that the T-Cell repertoire of the astronaut changes to become more specific to environmental taxa, suggesting that continual microbial and immune monitoring can help guide spaceflight mission planning, health monitoring, and habitat design.
- Open Access
Obesity and Race Alter Gene Expression in Skin
Obesity is accompanied by dysfunction of many organs, but effects on the skin have received little attention. We studied differences in epithelial thickness by histology and gene expression by Affymetrix gene arrays and PCR in the skin of 10 obese (BMI 35-50) and 10 normal weight (BMI 18.5-26.9) postmenopausal women paired by age and race. Epidermal thickness did not differ with obesity but the expression of genes encoding proteins associated with skin blood supply and wound healing were altered. In the obese, many gene expression pathways were broadly downregulated and subdermal fat showed pronounced inflammation. There were no changes in skin microbiota or metabolites. African American subjects differed from Caucasians with a trend to increased epidermal thickening. In obese African Americans, compared to obese Caucasians, we observed altered gene expression that may explain known differences in water content and stress response. African Americans showed markedly lower expression of the gene encoding the cystic fibrosis transmembrane regulator characteristic of the disease cystic fibrosis. The results from this preliminary study may explain the functional changes found in the skin of obese subjects and African Americans.
Open AccessObesity and Race Alter Gene Expression in Skin
Obesity is accompanied by dysfunction of many organs, but effects on the skin have received little attention. We studied differences in epithelial thickness by histology and gene expression by Affymetrix gene arrays and PCR in the skin of 10 obese (BMI 35-50) and 10 normal weight (BMI 18.5-26.9) postmenopausal women paired by age and race. Epidermal thickness did not differ with obesity but the expression of genes encoding proteins associated with skin blood supply and wound healing were altered. In the obese, many gene expression pathways were broadly downregulated and subdermal fat showed pronounced inflammation. There were no changes in skin microbiota or metabolites. African American subjects differed from Caucasians with a trend to increased epidermal thickening. In obese African Americans, compared to obese Caucasians, we observed altered gene expression that may explain known differences in water content and stress response. African Americans showed markedly lower expression of the gene encoding the cystic fibrosis transmembrane regulator characteristic of the disease cystic fibrosis. The results from this preliminary study may explain the functional changes found in the skin of obese subjects and African Americans.